Anjianning-BioRay

2020 官网升级中！现在您访问官网的浏览器设备分辨率宽度低于1280px
请使用高分辨率宽度访问。

PRODUCTS

We develop and manufacture medicines of the highest quality

Scrllo Down

View Products

Anjianning

Anruize Anruixi Anshuzheng Anbaite Anbainuo Anjianning

Anjianning^® biosimilar adalimumab

Indications

Rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriasis, pediatric plaque psoriasis, crohn's disease, pediatric crohn’s disease, uveitis

Product Summary

Biosimilar adalimumab (Humira)
Fully human monoclonal antibody against Tumor Necrosis Factor alpha
First approval in China in 2019 with numerous new indications under review for expansion
The second product BioRay developed in-house receiving marketing authorization in China

To Learn More

TO TOP